Related Experiment Video
Updated: Jul 15, 2026
07:36
Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
Possible link between NO concentrations and COX-2 expression in systems treated with soy-isoflavones
Jang-In Shin1, Yun-Kyung Lee, Young Min Kim
1Department of Food and Nutrition, Hannam University, Daejeon 306-791, Korea.
Annals of the New York Academy of Sciences
|April 4, 2007
Summary
Soy-isoflavones significantly boost nitric oxide (NO) production and cyclooxygenase-2 (COX-2) expression, impacting inflammatory pathways. Genistein, a soy isoflavone, also modulates cancer cell responses to NO.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Nitric oxide (NO) is crucial for cell signaling, especially during inflammation and cancer.
- Cyclooxygenase (COX), particularly COX-2, synthesizes prostanoids and is implicated in inflammatory processes.
- The interplay between NO and COX-2 expression is complex, with studies showing both inhibitory and stimulatory effects.
Purpose of the Study:
- To investigate the impact of soy-isoflavones, specifically genistein, on nitric oxide (NO) production.
- To examine the effect of soy-isoflavones on cyclooxygenase-2 (COX-2) gene expression and prostaglandin E2 (PGE2) levels.
- To explore the molecular mechanisms underlying these effects, including signaling pathways and cancer cell responses.
Main Methods:
- Assessing NO production in cells treated with soy-isoflavones.
- Analyzing endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) expression.
- Measuring COX-2 gene expression and PGE2 concentrations.
- Investigating the roles of ERK-1/2, p38, and AMP-activated protein kinase (AMPK) signaling pathways.
- Utilizing NO donors like sodium nitroprusside (SNP) in mammalian cancer systems.
Main Results:
- Soy-isoflavones markedly increased NO production without altering eNOS or iNOS expression.
- Elevated COX-2 expression and PGE2 concentrations were observed alongside increased NO.
- The stimulatory effect of soy-isoflavones on COX-2 was modulated by ERK-1/2 and p38 pathways.
- In cancer cells, genistein reduced COX-2 upregulation induced by an NO donor, potentially via AMPK activation.
Conclusions:
- Soy-isoflavones enhance NO production and COX-2/PGE2 expression, suggesting a role in inflammatory modulation.
- Specific signaling pathways (ERK, p38, AMPK) mediate the effects of soy-isoflavones on NO and COX-2.
- Genistein exhibits potential in modulating cancer cell responses involving NO and COX-2 pathways.
Related Concept Videos
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...